Merck & Co., Inc. (MRK)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Merck & Co., Inc. (MRK) is up 11.5% since the beginning of the year. At $115 per share, MRK is trading 7.7% below its 52-week high of $125. Investors who bought $1,000 worth of MRK shares 5 years ago would now be looking at an investment worth $1,788.

Merck & Co., Inc. (MRK) has returned 11.50% so far this year and 51.19% over the past 12 months. Over the last ten years, MRK has returned 11.42% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Jan 13, 1978, MRK's average daily return is +0.06%, while the average monthly return is +1.20%. At this rate, an investment would double in approximately 4.8 years.

Historically, 57% of months were positive and 43% were negative. The best month was Oct 1999 with a return of +22.8%, while the worst month was Sep 2004 at -26.0%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 9 months.

On a daily basis, MRK closed higher 50% of trading days. The best single day was Feb 18, 2005 with a return of +13.0%, while the worst single day was Sep 30, 2004 at -26.8%.

Merck & Co., Inc. has an annualized alpha of 7.12%, beta of 0.75, and R2 of 0.27 versus S&P 500 Index. Calculated based on daily prices since January 13, 1978.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (82.14%) than losses (65.64%) - typical of diversified or defensive assets.
• R2 of 0.27 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

MRK ranks 88 for risk / return — in the top 88% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

Merck & Co., Inc. provided a 3.07% dividend yield over the last twelve months, with an annual payout of $3.55 per share. The company has been increasing its dividends for 21 consecutive years.

The table displays the monthly dividend distributions for Merck & Co., Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Merck & Co., Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Merck & Co., Inc. was 68.61%, occurring on Mar 9, 2009. Recovery took 1239 trading sessions.

The current Merck & Co., Inc. drawdown is 7.06%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Merck & Co., Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Merck & Co., Inc. is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.